Philip Szekeres

7.6k citations

31 papers · 2.3k indexed · h-index 21

Endocrine and Autonomic Systems top 2%
Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology 12
- Neuroscience and Neuropharmacology Research 4
Physiology top 2%
- Alzheimer's disease research and treatments 5
Physiology top 5%
- Alzheimer's disease research and treatments 5
Neurology top 5%
Molecular Biology
- Receptor Mechanisms and Signaling 18
- 14-3-3 protein interactions 3
- Prion Diseases and Protein Misfolding 2
Cell Biology
- Microtubule and mitosis dynamics 3
Computational Theory and Mathematics
- Computational Drug Discovery Methods 2

Co-authors: Gary B. Willars Paul J. Brighton Shelagh Wilson Paul R. Murdock Nabil A. Elshourbagy Alan Wise J. Michael Edwardson John R. Traynor
Cited by: Endocrine and Autonomic Systems Cellular and Molecular Neuroscience Physiology
Journals: Journal of Biological Chemistry (6 papers)Journal of Clinical Oncology (1 paper)Journal of Neuroscience (1 paper)
Partner nations: United Kingdom United States Russia

In The Last Decade

Philip Szekeres

30 papers receiving 2.3k citations

Peers

Countries citing papers authored by Philip Szekeres

Since Specialization

Citations

This map shows the geographic impact of Philip Szekeres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Szekeres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Szekeres more than expected).

Fields of papers citing papers by Philip Szekeres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Szekeres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Szekeres. The network helps show where Philip Szekeres may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip Szekeres, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Szekeres Line = papers co-authored together Philip Szekeres links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Early ctDNA Dynamics Inform First-Line Therapy in Patients with Extensive-Stage Small Cell Lung Cancer Clinical Cancer Research ·Carmela Ciardullo,Luis Tobalina,T. Hedley Carr,Philip Szekeres,Silvija Kraljevic,Lauren A. Byers,Giulia Fabbri	2025	1
2	CLARITY-PanTumor01: A phase 2 trial of the claudin 18.2-specific antibody-drug conjugate AZD0901 (CMG901) in patients with CLDN18.2-expressing advanced solid tumors. Journal of Clinical Oncology ·Alexander G. Raufi,Lipika Goyal,Elizabeth Smyth,Philip Szekeres,Marcella Petrone,Rosalind Hobson,Kenneth S. Thress,Makoto Origuchi,Jyoti Nehra,Jessica S. Brown,Rakesh Kumar,Italia Grenga,Laura Barker,Yelena Y. Janjigian,Kohei Shitara	2024	3
3	Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation Journal of Alzheimer s Disease ·Emma Mead,Dimitra Kestoras,Yolanda Gibson,Lucy Hamilton,Ross Goodson,Sophie Jones,Sarah Eversden,Peter Davies,Michael J. O’Neill,Michael Hutton,Philip Szekeres,Joanna Wolak	2016	15
4	Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates Journal of Biological Chemistry ·Benjamin Falcon,Annalisa Cavallini,Rachel Angers,Sarah Glover,Tracey K. Murray,Luanda Barnham,Samuel J. Jackson,Michael O’Neill,Adrian M. Isaacs,Michael Hutton,Philip Szekeres,Michel Goedert,Suchira Bose	2014	199
5	An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease Journal of Biological Chemistry ·Annalisa Cavallini,Suzanne Brewerton,Amanda Bell,Samantha Sargent,Sarah Glover,Clare Hardy,Roger E. Moore,John Calley,Devaki Ramachandran,Michael Poidinger,Eric Karran,Peter Davies,Michael Hutton,Philip Szekeres,Suchira Bose	2013	95
6	Development of Homogeneous 384-Well High-Throughput Screening Assays for Aβ1-40 and Aβ1-42 Using AlphaScreen™ Technology SLAS DISCOVERY ·Philip Szekeres,Kaitlin Leong,Theresa A. Day,Ann E. Kingston,Eric Karran	2008	31
7	Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat Psychopharmacology ·Janice W. Smith,Adrian J. Mogg,Elisiana Tafi,Eleanor Peacey,Ian A. Pullar,Philip Szekeres,Mark D. Tricklebank	2006	88
8	Neuroreplacement, Growth Factor, and Small Molecule Neurotrophic Approaches for Treating Parkinson's Disease International review of neurobiology ·Michael J. O’Neill,Marcus J. Messenger,Viktor Lakics,Tracey K. Murray,Eric Karran,Philip Szekeres,Eric S. Nisenbaum,Kalpana Merchant	2006	9
9	Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles Pharmacological Reviews ·Paul J. Brighton,Philip Szekeres,Gary B. Willars	2004	206
10	Radioligand Binding and Functional Characterization of Recombinant Human NmU1 and NmU2 Receptors Stably Expressed in Clonal Human Embryonic Kidney-293 Cells Pharmacology ·Nambi Aiyar,Jyoti Disa,James J. Foley,Peter T. Buckley,William E. Wixted,Mark Pullen,Usman Shabon,Edward Dul,Philip Szekeres,Nabil A. Elshourbagy,Henry M. Sarau,Edward R. Appelbaum,Jane E. Bolaky	2004	16
11	Signaling and Ligand Binding by Recombinant Neuromedin U Receptors: Evidence for Dual Coupling to Gαq/11 and Gαi and an Irreversible Ligand-Receptor Interaction Molecular Pharmacology ·Paul J. Brighton,Philip Szekeres,Alan Wise,Gary B. Willars	2004	54
12	GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function Molecular Brain Research ·Darren J. Moore,Paul R. Murdock,Jeannette M. Watson,Richard L. M. Faull,Henry J. Waldvogel,Philip Szekeres,Shelagh Wilson,Katie B. Freeman,Piers C. Emson	2003	85
13	Molecular cloning and characterisation of a novel GABAB-related G-protein coupled receptor Molecular Brain Research ·Andrew R. Calver,David Michalovich,T Testa,Melanie J. Robbins,Céline Jaillard,J Hill,Philip Szekeres,Charles Kornreich,Sabine Jourdain,Joanna D. Holbrook,Izzy Boyfield,Neha Patel,Andrew D. Medhurst,Menelas N. Pangalos	2003	43
14	Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid Journal of Biological Chemistry ·Alan Wise,Steven M. Foord,Neil J. Fraser,Ashley Barnes,Nabil A. Elshourbagy,Michelle M. Eilert,Diane M. Ignar,Paul R. Murdock,Klaudia Steplewski,Andrew R. Green,Andrew J. Brown,Simon J. Dowell,Philip Szekeres,David G. Hassall,Fiona H. Marshall,Shelagh Wilson,Nicholas B. Pike	2003	440
15	Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor Journal of Biological Chemistry ·J Hill,Malcolm Duckworth,Paul R. Murdock,Gillian Rennie,Cibele Sabido-David,Robert S. Ames,Philip Szekeres,Shelagh Wilson,Derk J. Bergsma,Israel Gloger,Dana S. Levy,Jon Chambers,Alison I. Muir	2001	186
16	Characterization of the binding of [¹²⁵I]‐human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor British Journal of Pharmacology ·Christopher J. Langmead,Philip Szekeres,Jonathan K. Chambers,S. Ratcliffe,Declan N.C. Jones,Warren D. Hirst,Gary Price,Hugh J. Herdon	2000	50
17	Receptor for the Pain Modulatory Neuropeptides FF and AF Is an Orphan G Protein-coupled Receptor Journal of Biological Chemistry ·Nabil A. Elshourbagy,Robert S. Ames,Laura R. Fitzgerald,James J. Foley,Jon Chambers,Philip Szekeres,Nicholas A. Evans,Dulcie B. Schmidt,Peter T. Buckley,George Dytko,Paul R. Murdock,Graeme Milligan,D. Alex Groarke,K. B. Tan,Usman Shabon,Parvathi Nuthulaganti,Da Yuan Wang,Shelagh Wilson,Derk J. Bergsma,Henry M. Sarau	2000	226
18	Effect of G Protein‐Coupled Receptor Kinase 2 on the Sensitivity of M4 Muscarinic Acetylcholine Receptors to Agonist‐Induced Internalization and Desensitization in NG108‐15 Cells Journal of Neurochemistry ·Eric Holroyd,Philip Szekeres,Rebecca Whittaker,Eamonn Kelly,J. Michael Edwardson	1999	17
19	Involvement of Receptor Cycling and Receptor Reserve in Resensitization of Muscarinic Responses in SH‐SY5Y Human Neuroblastoma Cells Journal of Neurochemistry ·Philip Szekeres,Jennifer Koenig,J. Michael Edwardson	1998	28
20	The Relationship between Agonist Intrinsic Activity and the Rate of Endocytosis of Muscarinic Receptors in a Human Neuroblastoma Cell Line Molecular Pharmacology ·Philip Szekeres,Jennifer Koenig,J. Michael Edwardson	1998	38

About Philip Szekeres

Philip Szekeres is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology, having authored 31 papers that have together received 2.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (12 papers), Alzheimer's disease research and treatments (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Microtubule and mitosis dynamics (3 papers), 14-3-3 protein interactions (3 papers), Prion Diseases and Protein Misfolding (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (398 citations), Cellular and Molecular Neuroscience (1.0k citations) and Physiology (130 citations). Philip Szekeres has collaborated with scholars based in United Kingdom, United States and Russia. Frequent co-authors include Gary B. Willars, Paul J. Brighton, Shelagh Wilson, Paul R. Murdock, Nabil A. Elshourbagy, Alan Wise, J. Michael Edwardson, John R. Traynor, Derk J. Bergsma and Jon Chambers. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact